Characterization of TEM-, SHV- and AmpC-type β-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine

International Journal of Food Microbiology

Volumn 124, Issue 2, 2008, Pages 183-187

  Rayamajhi, Nabin ^a   Kang, Sang Gyun ^a   Lee, Deog Yong ^a   Kang, Mi Lan ^a   Lee, Su In ^a   Park, Kyung Yoon ^b   Lee, Hee Soo ^c   Yoo, Han Sang ^a  

^a KRF Zoonotic Disease Priority Research Institute   (South Korea)

^b Clinical Pathology Lab   (South Korea)

^c Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

lactam; lactamases; Enterobacteriaceae; Plasmid

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEPHALOSPORIN;

ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SOUTHERN BLOTTING; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORIN RESISTANCE; CONJUGATION, GENETIC; DNA PROBES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SWINE;

ANIMALIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA ENTERITIDIS; SUIDAE;

EID: 43749120919     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2008.03.009     Document Type: Article

References (26)

1. Black A.J., Thomson K.S., Buynak J.D., and Pitout D. Evaluation of β-lactamase inhibitor in disk test for detection of plasmid-mediated AmpC β-lactamases in well-characterized clinical strains of Klebsiella spp. Journal of Clinical Microbiology 439 8 (2005) 4168-4171
2. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clinical Microbiology Reviews 14 (2001) 933-951
3. Bush K. New beta lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clinical Infectious Diseases 32 (2001) 1085-1089
4. Clinical and Laboratory Standards Institute. Performance Standards for Anti-microbial Susceptibility Testing; 15th Informational Supplement. M100-S15 (2006), Clinical and Laboratory Standards Institute (CLSI), Wayne, Pa
5. Jacoby G.A., and Medeiros A.A. More extended-spectrum of β-lactamases. Antimicrobial Agents and Chemotherapy 35 (1991) 1697-1704
6. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., Kim Y.H., Jeong B.C., and Lee S.H. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. Journal of Clinical Microbiology 42 (2004) 2902-2906
7. Kim S., Kim J., Kang Y., Park Y., and Lee B. Occurrence of extended-spectrum ß-lactamases in members of the genus Shigella in the Republic of Korea. Journal of Clinical Microbiology 42 (2004) 5264-5269
8. Kim Y.T., Kim T.U., and Baik H.S. Characterization of extended-spectrum ß-lactamase genotype TEM, SHV, and CTX-M producing Klebsiella pneumoniae isolated from clinical specimens in Korea. Journal of Microbiology and Biotechnology 16 (2006) 889-895
9. Korea Food and Drug Administration (KFDA). Establishment of Control System of Antibiotics for Livestocks (2005), Korea food and drug administration, Seoul, Korea
10. Lee S.H., Kim J.Y., Lee G.S., Cheon S.H., An Y.J., Jeong S.H., and Lee K.J. Characterization of blaCMY-11, an AmpC-type plasmid-mediated β-lactamase gene in Korean isolate of Escherichia coli. Journal of Antimicrobial Chemotherapy 49 (2002) 269-273
11. Lee K., Yong D., Yum J.H., Kim H.H., and Chong Y. Diversity of TEM-52 extended-spectrum ß-lactamase-producing non-typhoidal Salmonella isolates in Korea. Journal of Clinical Microbiology 52 (2003) 493-496
12. Lee K.W., Yong D.G., Choi Y.S., Yum J.H., Kim J.M., Woodford N., Livermore D.M., and Chong Y. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. International Journal of Antimicrobial Agents 29 (2007) 201-206
13. TEM genes. Antimicrobial Agents and Chemotherapy 44 (2000) 2709-2714
14. Li X.-Z., Mehrotra M., Ghimire S., and Adewoye L. Beta-lactam resistance and beta-lactamases in bacteria of animal origin. Veterinary Microbiology 121 (2007) 97-214
15. Orencia M.C., Yoon J.S., Stemmer N.W.P.C., and Stevens R.C. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nature Structural Biology 8 (2001) 238-242
16. Pai H.J., Lyu S., Lee J.H., Kim J., Kwon Y., Kim J.W., and Choe K.W. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. Antimicrobial Agents and Chemotherapy 37 (1999) 1758-1763
17. Pai H.J., Kang C.I., Byeon J.H., Lee D.L., Park W.B., Kim H.B., Kim E.C., Oh M.D., and Choe K.W. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 48 (2004) 3720-3728
18. Perez-Perez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase gene in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 40 (2002) 2153-2162
19. Salmon S.A., Watts J.L., Case L.J., Hoffman C.A., Wegener H.C., and Yancey R.J. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. Journal of Clinical Microbiology 33 (1995) 2435-2444
20. Song W., Kim J., Kim H., Yong D., Jeong S., Park M., and Lee K. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagnostic Microbiology and Infectious Disease 55 (2004) 219-224
21. Tasli H., and Bahar I.H. Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Japanese Journal of Infectious Disease 58 (2005) 162-167
22. Thomson K.S., and Sanders C.C. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double disk and three-dimensional tests. Antimicrobial Agents and Chemotherapy 36 (1992) 1877-1882
23. Veterinary and Public Health Test Standardization Group on behalf of SGDIA. UK National Guide Lines for Laboratories: Detection and Characterization of Betalactamase Resistance in Gram-negative Bacteria of Veterinary Significance (2005)
24. Winokur P.L., Vonstein D.L., Hoffman L.J., Uhlenhopp E.K., and Doern G.V. Evidence of transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals to humans. Antimicrobial Agents and Chemotherapy 45 (2001) 2716-2722
25. Wu T.L., Chia J.H., Su L.H., Chiu C.H., Kuo A.J., Ma L., and Siu L.K. CMY-2 β-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Cholerasuis and Typhimurium. Antimicrobial Agents and Chemotherapy 116 (2007) 283-286
26. Yan J.J., Ko W.C., Wu J.J., Tasi S.H., and Chuang C.L. Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistance Escherichia coli in Taiwanese teaching hospital. Journal of Clinical Microbiology 42 (2004) 3329-3332